Page 3 - Andreas Bergmann News Today

Investegate announcements from SphingoTec GmbH, Endothelial Function Biomarker bio-ADM to Support Risk Stratification and Clinical Management of COVID-19 Patients

 E-Mail Aachen, Germany and Hennigsdorf/Berlin, Germany, May 4, 2021 - German University Hospital Uniklinik RWTH Aachen ("Uniklinik RWTH Aachen") and diagnostics company SphingoTec GmbH ("SphingoTec") today announced that the endothelial function biomarker bio-ADM aids in the early risk stratification and management of patients suffering from severe COVID-19, in need for escalated intensive care treatment (1). A team lead by the clinical researchers at Uniklinik RWTH Aachen has shown that high...

Ella Paradis Receives The Startup Weekly’s 2021 Consumer Products & Services to Watch Award Share Article This Prestigious Award Highlights Mainstream Recognition of the Sexual Health & Wellness Industry, Breaking Barriers & Stigmas Relating to Sex As the first sexual health & wellness company to receive this award, or any recognition from The Start Up Weekly, this exemplifies how mainstream stigmas relating to sex are being lifted, further highlighting how the pandemic changed this industry ...

Loading video... VIDEO: Researchers have published new insights into the causes of mortality in sepsis. Loss of endothelial function is induced through two different pathophysiological processes and is a major driver of septic... view more  Credit: © SphingoTec GmbH, 2021 Researchers have published new insights into the causes of mortality in sepsis Loss of endothelial function is induced through two different pathophysiological processes and is a major driver of septic shock, a life-t...

(1) Researchers have published new insights into the causes of mortality in sepsis Loss of endothelial function is induced through two different pathophysiological processes and is a major driver of septic shock, a life-threatening drop in blood pressure The first pathway originates in the loss of the endothelial barrier triggering an increased production of the repair hormone bioactive Adrenomedullin (bio-ADM), which also has the undesired side effect of vasodilation The second threat acting o...

DGAP-News: Proen ... DGAP-News: Proenkephalin (penKid(R)) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients vom 16.12.2020, 10:00 Uhr Bild: pixabay.com DGAP-News: SphingoTec GmbH / Key word(s): Scientific publication/Statement Proenkephalin (penKid(R)) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients 16.12.2020 / 10:00 The issuer is solely respo...

Press release content from Accesswire. The AP news staff was not involved in its creation. Proenkephalin (penKid(R)) Included in the ADQI Consensus Statements Publication as Functional Kidney Biomarker for the Management of AKI Patients December 16, 2020 GMT The latest consensus meeting of international experts in critical care and nephrology supports the use of novel biomarkers in the prevention and management of Acute Kidney Injury (AKI) The consensus recommends using a combination of damage ...

(1) DGAP-News: SphingoTec GmbH / Key word(s): Scientific publication/Statement Proenkephalin (penKid(R)) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients 16.12.2020 / 10:00 The issuer is solely responsible for the content of this announcement. The latest consensus meeting of international experts in critical care and nephrology supports the use of novel biomarkers in the prevention and management of Acute Kidney Injury (A...

Proenkephalin (penKid®) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients The latest consensus meeting of international experts in critical care and nephrology supports the use of novel biomarkers in the prevention and management of Acute Kidney Injury (AKI) The consensus recommends using a combination of damage and functional biomarkers together with clinical information for routine practice Proenkephalin (penKid®), th...

 E-Mail Uniklinik RWTH Aachen is the first hospital to implement SphingoTecs innovative biomarkers in clinical routine with the aim of making intensive care diagnostics more precise The biomarkers for the real-time assessment of kidney function (penKid®) and endothelial function (bio-ADM®) are pioneering new diagnostic pathways in critical care settings Following a positive initial clinical evaluation of penKid® and bio-ADM®, the University Hospital RWTH Aachen has transferred the innovati...